Search Results - "Maitland, Karlene A"

SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase by Hou, Xiuyun, Xu, Shanqin, Maitland-Toolan, Karlene A., Sato, Kaori, Jiang, Bingbing, Ido, Yasuo, Lan, Fan, Walsh, Kenneth, Wierzbicki, Michel, Verbeuren, Tony J., Cohen, Richard A., Zang, Mengwei

“…Resveratrol may protect against metabolic disease through activating SIRT1 deacetylase. Because we have recently defined AMPK activation as a key mechanism for…”
Get full text

Polyphenols Stimulate AMP-Activated Protein Kinase, Lower Lipids, and Inhibit Accelerated Atherosclerosis in Diabetic LDL Receptor–Deficient Mice by MENGWEI ZANG, SHANQIN XU, MAITLAND-TOOLAN, Karlene A, ZUCCOLLO, Adriana, XIUYUN HOU, BINGBING JIANG, WIERZBICKI, Michel, VERBEUREN, Tony J, COHEN, Richard A

“…Polyphenols Stimulate AMP-Activated Protein Kinase, Lower Lipids, and Inhibit Accelerated Atherosclerosis in Diabetic LDL Receptor–Deficient Mice Mengwei Zang…”
Get full text

The Thromboxane Receptor Antagonist S18886 Attenuates Renal Oxidant Stress and Proteinuria in Diabetic Apolipoprotein E-Deficient Mice by Xu, Shanqin, Jiang, Bingbing, Maitland, Karlene A, Bayat, Hossein, Gu, Jiali, Nadler, Jerry L, Corda, Stefano, Lavielle, Gilbert, Verbeuren, Tony J, Zuccollo, Adriana, Cohen, Richard A

“…The Thromboxane Receptor Antagonist S18886 Attenuates Renal Oxidant Stress and Proteinuria in Diabetic Apolipoprotein E-Deficient Mice Shanqin Xu 1 , Bingbing…”
Get full text

Glucose-6-Phosphate Dehydrogenase Deficiency Decreases Vascular Superoxide and Atherosclerotic Lesions in Apolipoprotein E−/− Mice by Matsui, Reiko, Xu, Shanqin, Maitland, Karlene A, Mastroianni, Roberto, Leopold, Jane A, Handy, Diane E, Loscalzo, Joseph, Cohen, Richard A

“…OBJECTIVE—Glucose-6-phosphate dehydrogenase (G6PD) is a key enzyme in the pentose phosphate pathway that is a major source of cellular NADPH. The purpose of…”
Get full text

Attenuated cardiovascular hypertrophy and oxidant generation in response to angiotensin II infusion in glutaredoxin-1 knockout mice by Bachschmid, Markus M., Xu, Shanqin, Maitland-Toolan, Karlene A., Ho, Ye-Shih, Cohen, Richard A., Matsui, Reiko

“…Glutaredoxin-1 (Glrx) is a thioltransferase that regulates protein S -glutathiolation. To elucidate the role of endogenous Glrx in cardiovascular disease, Glrx…”
Get full text

Glucose-6 phosphate dehydrogenase deficiency decreases the vascular response to angiotensin II by MATSUI, Reiko, SHANQIN XU, MAITLAND, Karlene A, HAYES, Antoinette, LEOPOLD, Jane A, HANDY, Diane E, LOSCALZO, Joseph, COHEN, Richard A

“…Glucose-6-phosphate dehydrogenase (G6PD) regulates production of the reduced form of NADPH through the pentose phosphate pathway. G6PD may therefore affect…”
Get full text

The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus by ZUCCOLLO, Adriana, CHAOMEI SHI, CORDA, Stefano, LAVIELLE, Gilbert, VERBEUREN, Tony J, COHEN, Richard A, MASTROIANNI, Roberto, MAITLAND-TOOLAN, Karlene A, WEISBROD, Robert M, MENGWEI ZANG, SHANQIN XU, BINGBING JIANG, OLIVER-KRASINSKI, Jennifer M, CAYATTE, Antonio J

“…S18886 is an orally active thromboxane A2 (TXA2) receptor (TP) antagonist in clinical development for use in secondary prevention of thrombotic events in…”
Get full text

SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein KinaseS by Hou, Xiuyun, Xu, Shanqin, Maitland-Toolan, Karlene A., Sato, Kaori, Jiang, Bingbing, Ido, Yasuo, Lan, Fan, Walsh, Kenneth, Wierzbicki, Michel, Verbeuren, Tony J., Cohen, Richard A., Zang, Mengwei

“…Resveratrol may protect against metabolic disease through activating SIRT1 deacetylase. Because we have recently defined AMPK activation as a key mechanism for…”
Get full text

The Thromboxane A 2 Receptor Antagonist S18886 Prevents Enhanced Atherogenesis Caused by Diabetes Mellitus by Zuccollo, Adriana, Shi, Chaomei, Mastroianni, Roberto, Maitland-Toolan, Karlene A., Weisbrod, Robert M., Zang, Mengwei, Xu, Shanqin, Jiang, Bingbing, Oliver-Krasinski, Jennifer M., Cayatte, Antonio J., Corda, Stefano, Lavielle, Gilbert, Verbeuren, Tony J., Cohen, Richard A.

“…Background— S18886 is an orally active thromboxane A 2 (TXA 2 ) receptor (TP) antagonist in clinical development for use in secondary prevention of thrombotic…”
Get full text